SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Neven Haltmayer, Senior Vice President and General Manager of the Video Business, resigned effective June 16, 2026, after 20 years of service, in connection with the completion of the Video Business sale.
View raw filing on EDGAR →Mr. Steven Berman, the former Chief Executive Officer, resigned effective June 3, 2026, as part of a mutual settlement agreement resolving disputes arising from his suspension in May 2024 and an internal investigation into allegations against him. The departure of a CEO following a governance crisis and investigation is material to investors' assessment of the company's leadership and stability.
View raw filing on EDGAR →Karen Hawkins, Chief Financial Officer and Secretary of Optex Systems Holdings, Inc., notified the Company on June 12, 2026 of her intention to resign effective December 31, 2026. The departure of a CFO is a material executive change that would affect a reasonable investor's assessment of the registrant's financial leadership and continuity. The filing explicitly states no disagreements or accounting issues were involved, confirming this is a straightforward departure disclosure.
View raw filing on EDGAR →Marco Fregenal was terminated as Chief Executive Officer, Principal Financial Officer, and Principal Accounting Officer, effective immediately, following an internal review that found conduct inconsistent with the Company's Code of Ethics. He also resigned as a director.
View raw filing on EDGAR →Two board members—Margaret FitzPatrick and Dr. Joanne Curley—notified the Company of their decisions not to stand for re-election at the 2026 Annual Meeting. Although they will remain in office until the end of their terms, the disclosure centers on their departure from the Board, which is material to investors assessing governance and board composition at a small-cap biotech company.
View raw filing on EDGAR →Stephen L. Johnson, Vice Chair and Chief Strategy Officer of American Airlines Group Inc., announced his retirement effective end of year 2026. This departure of a senior named executive officer is material to investors assessing the company's leadership continuity and strategic direction.
View raw filing on EDGAR →The Cincinnati Insurance Company's Chief Information Officer retired, as disclosed via a news release dated June 16, 2026. This departure of a named executive officer in a critical technology leadership role is material to investors given its impact on the registrant's management structure and operational continuity.
View raw filing on EDGAR →Bruce T. Crawford resigned from the Company's Board of Directors effective June 16, 2026, due to his appointment as president and Chief Executive Officer of AFCEA International. This is a clear director departure. While the filing notes no disagreement with the Company, the loss of a board member is material to investors assessing governance and board composition.
View raw filing on EDGAR →Six directors (Heather L. Mason, Sravan K. Emany, Sigurd C. Kirk, William T. McKee, David M. Stark, and Mark L. Reisenauer) voluntarily resigned as directors, and all officers ceased service, in connection with the merger transaction.
View raw filing on EDGAR →The report discloses the removal of two independent directors, Mr. Wang Yiyun and Mr. Liu Jun, effective June 9, 2026. Mr. Wang Yiyun held significant governance roles as Chair of the Compensation Committee and member of the Audit and Nominating committees; Mr. Liu Jun served on all three committees. The removal of multiple independent directors with substantial committee responsibilities is a material governance event affecting board composition and oversight structure.
View raw filing on EDGAR →Dr. William Rote, Chief Research Officer, provided notice of his intention to retire effective February 17, 2027. While the filing also discloses Dr. Jula Inrig's appointment as Executive Vice President, Head of R&D and Chief Medical Officer, the principal disclosed action centers on Dr. Rote's departure from a senior executive role overseeing research operations. The departure of a C-suite officer responsible for research is material to investors assessing the company's leadership continuity and R&D capabilities.
View raw filing on EDGAR →Nicholas J. Etten resigned as a member of the Company's Board of Directors effective June 2026. This is a clear departure of a director, which is material to investors as board composition affects governance and oversight. The resignation is the principal disclosed action under Item 5.02.
View raw filing on EDGAR →The filing discloses the resignation of Chath Weerasinghe as Chief Financial Officer and Chief Operating Officer (effective three months from June 11, 2026), along with the resignations of three directors (Tim Nixdorff, Berndt Hauptkorn, and Adam Epstein) all citing disagreements over strategic direction and corporate governance. The departure of a CFO and COO, combined with multiple director departures within days, represents material executive departures that would affect a reasonable investor's assessment of management stability and governance.
View raw filing on EDGAR →Stephen Reitman, a director of Capri Holdings Limited, has expressed his intention not to stand for re-election to the Board, with his term ending at the conclusion of the 2026 Annual Meeting on July 29, 2026. This constitutes a departure of a director from the Board. While the disclosure notes his retirement is not due to disagreement with the Company, the material fact is the loss of a board member, which is typically material to investors assessing governance and board composition.
View raw filing on EDGAR →Jim H. Snabe, a director and special advisor to the CEO, is taking a leave of absence from the Board effective immediately due to his appointment as Special Envoy to the European Commission for Industrial Artificial Intelligence. While framed as a temporary leave, the disclosure states he will not stand for re-election at the 2026 annual meeting and will have no voting or advisory duties during the absence, effectively removing him from active governance. The Board reduced its size from twelve to eleven directors, signaling a material change in board composition.
View raw filing on EDGAR →Brady Priest's departure as Chief Executive Officer of Clover Care Services, effective July 3, 2026, is the principal disclosed action. Although the Company states it will not appoint a successor and will reorganize responsibilities among existing leadership, the core event is an executive officer leaving his position. The departure is material as it affects the leadership structure of a significant business unit (the Company's home-care business) and would inform a reasonable investor's assessment of management continuity and operational integration.
View raw filing on EDGAR →Five directors departed from Honeywell's Board: Craig Arnold, William Ayer, D. Scott Davis, Deborah Flint, and Jillian Evanko. Four departures are conditioned on the Spin-Off consummation and tied to anticipated appointments to Honeywell Aerospace's board, while Evanko's departure is immediate due to professional commitments.
View raw filing on EDGAR →Carey S. Roberts, Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary, notified Ventas of her intention to resign effective June 26, 2026.
View raw filing on EDGAR →Kyle Huffman, the Chief Accounting Officer, notified the Company of his intention to resign effective July 10, 2026. While the filing also mentions that James Di Bartolo (CFO) will assume accounting officer responsibilities, the principal disclosed action is Huffman's departure from his officer position. The departure of a CAO is material to investors as it affects the registrant's financial reporting oversight and internal controls.
View raw filing on EDGAR →The exhibit announces the departure of Cynthia L. Paul from Allot's Board of Directors, effective June 15, 2026. She served since November 2022 and supported the company through operational transformation and financial strengthening. This is a clear board member departure disclosure, matching the exec_departure category. The materiality is supported by her tenure and the company's emphasis on her role during a critical transformation period, though the departure is characterized as voluntary due to other business demands rather than adverse circumstances.
View raw filing on EDGAR →Chief Medical Officer Dr. Hussein Sweiti resigned effective June 14, 2026, and Chief Financial Officer Ryan Daws separated effective July 15, 2026, representing material departures of two senior executives.
View raw filing on EDGAR →Jonathan Baldwin, Executive Vice President of Government Solutions, is departing the Company effective July 9, 2026. The disclosure centers on the departure itself and associated severance benefits under his employment agreement. While severance terms are mentioned, the principal disclosed action is the executive's departure, making this an exec_departure event.
View raw filing on EDGAR →Jason Secore, Chief Financial Officer, and the company mutually agreed to begin a transition of his responsibilities effective June 9, 2026, with Mr. Secore remaining in the CFO role during the transition period.
View raw filing on EDGAR →Luan Pham ceased serving as President of Byrna Technologies on June 13, 2026, with his employment terminated without cause as part of a restructuring of the Company's sales and marketing organization.
View raw filing on EDGAR →The 6-K discloses that Takayuki Nakano resigned as a member of the Board of Directors on May 7, 2026. The filing explicitly states the resignation was not due to disagreement with operations or policies, and provides an updated list of executive officers and directors following the departure. This is a clear executive departure event requiring disclosure under Item 5.02 equivalent standards for foreign private issuers.
View raw filing on EDGAR →The filing discloses the resignation of three key executives effective June 11, 2026: Mr. Wai Ho Chan (Director and Chairman), Mr. Sze Hon Johnson Chen (Director and Chief Executive Officer), and Ms. Ka Lee Lam (Independent Director). While the filing also announces appointments of replacements, the principal disclosed action is the departure of these senior officers, particularly the CEO and Chairman, which materially affects the company's leadership structure and would be material to investors.
View raw filing on EDGAR →Mari J. Baker, a director and Chair of the Executive Compensation and Development Committee, notified the Board on June 10, 2026 of her intent not to stand for reelection at the September 24, 2026 Annual Meeting, completing her 15-year tenure. This is a material departure of a senior board member with significant committee leadership responsibilities, affecting board composition and governance structure.
View raw filing on EDGAR →Eva Boratto, a Board member of UPS, resigned effective immediately on June 13, 2026, due to her appointment as CFO of Cencora, Inc. This is a clear executive departure—a director leaving the Board. Board composition changes are material to investors as they affect governance and oversight. The resignation was not due to disagreement, but the departure itself is the salient disclosed event.
View raw filing on EDGAR →Elliott Rodgers, a Board member, tendered his resignation effective June 15, 2026, in connection with his appointment as an executive officer at Kohl's Corporation. The principal disclosed action is a director's departure from the Board. While the filing notes the Board intends to decrease size to 11 directors, the core event is Rodgers' resignation, making this an exec_departure rather than a routine administrative matter.
View raw filing on EDGAR →The disclosure centers on Kristen Johnson's separation from H2O America, effective July 3, 2026, following a mutual agreement on June 10, 2026. The Company classified the separation as "without cause" and committed to severance payments under her employment agreement. This is a clear executive departure event, material to investors as it affects the composition of management and involves severance obligations.
View raw filing on EDGAR →Tim Walbert, a Board member of Sagimet Biosciences Inc., tendered his resignation from the Board effective June 12, 2026, due to other commitments.
View raw filing on EDGAR →Jami A. Statham, Senior Vice President, General Counsel and Corporate Secretary, notified the Company on June 10, 2026 of her intention to step down effective July 9, 2026. While the disclosure includes compensatory arrangement details (continued salary, benefits, equity vesting, and bonus), the principal disclosed action is the departure of a named executive officer from a senior legal and governance role. The departure is the salient event driving the filing.
View raw filing on EDGAR →Michael Amoroso resigned as a member of the Board of Directors of Abeona Therapeutics Inc. effective immediately on June 11, 2026, and also resigned from the Nominating and Corporate Governance Committee. This is a clear executive departure disclosed under Item 5.02, and board departures are material events affecting the registrant's governance structure and investor assessment.
View raw filing on EDGAR →Mr. Chay Weei Jye resigned from his position as Co-Chief Executive Officer and as a director of Black Titan Corporation, effective June 12, 2026. The departure of a named executive officer at the C-suite level is a material event that would affect a reasonable investor's assessment of the registrant's leadership and governance.
View raw filing on EDGAR →Matthew Faber resigned from Tri-County Financial Group's Board of Directors, effective June 11, 2026. The filing discloses a director departure under Item 5.02, with explicit confirmation that the resignation was not due to disagreement with the Company. Board departures are material events affecting the composition of the registrant's governance structure.
View raw filing on EDGAR →William Conkling, Executive Vice President and Chief Financial Officer, resigned effective June 15, 2026. The company disclosed his departure via press release on June 12, 2026, and entered into a separation agreement with consulting fee arrangements.
View raw filing on EDGAR →Jason Pernell, President of Trulieve Cannabis Corp., terminated his employment effective immediately on June 11, 2026, pursuant to a mutual agreement and Separation Agreement. The disclosure centers on the departure of a named executive officer from a senior position, with associated severance arrangements including cash payment, COBRA continuation, and equity vesting. This is a material executive departure that would affect investor assessment of the company's leadership and operational continuity.
View raw filing on EDGAR →Rajeev Date's resignation as Lead Independent Director effective immediately is the principal disclosed action. While the filing also mentions Craig Broderick's appointment as the new Lead Independent Director, the core event centers on Date's departure after nearly 13 years of service, including his role as Lead Independent Director since November 2024. The departure of a long-tenured lead independent director is material to investors assessing board governance and continuity.
View raw filing on EDGAR →E. Ted Botner, Executive Vice President, General Counsel and Corporate Secretary, is retiring from his position effective immediately with a final departure date of June 30, 2026. While the filing also mentions the appointment of Roger W. Landes as Interim General Counsel, the principal disclosed action is Botner's departure from a senior executive role. The departure of a named executive officer holding the General Counsel position is material to investors.
View raw filing on EDGAR →Eight directors (Brian J. G. Pereira, Benjamin L. Palleiko, William Fairey, Laurence Reid, Bethany Sensenig, Nancy Stuart, Patrick Treanor, and Edward W. Unkart) resigned from the Company's board and all committees effective immediately in connection with the merger consummation, with no disagreement cited.
View raw filing on EDGAR →Mr. Philip R. Martens retired from his positions as member and Chairman of the Board effective June 11, 2026. While the filing also discloses Mr. Venturelli's election as Chairman, the principal disclosed action centers on Martens' departure from the chairmanship—a material executive transition at the board level. The retirement of a sitting Chairman is a material event affecting corporate governance and investor assessment of the company.
View raw filing on EDGAR →The filing discloses the removal of Christodoulos Tzoutzakis as Chief Operating Officer and Chief Technology Officer, effective June 11, 2026. This is a departure of a named executive officer from material positions. Although the Board explicitly states the removal was "without cause" and not due to disagreement or operational issues, the principal disclosed action is a person leaving executive roles, which is the defining characteristic of exec_departure.
View raw filing on EDGAR →Eric Kash resigned as Executive Vice President and Board member effective June 5, 2026. While the filing also discloses severance terms ($125,000 in installments, vested stock options, and accrued vacation), the principal disclosed action is the departure itself. The resignation was not due to disagreement, and the severance arrangement is ancillary to the departure event. This is material as executive departures affect investor assessment of management stability and governance.
View raw filing on EDGAR →Bryan D. Coy resigned as Executive Vice President and Chief Financial Officer on June 10, 2026. While the filing also discloses the appointment of Brett A. Correia as interim CFO, the primary disclosed action centers on Coy's departure from a senior executive role. The departure of a CFO is material to investors assessing management continuity and financial oversight. The severance arrangement (accelerated vesting of 21,327 restricted shares and up to six months of base salary) further underscores the significance of this executive departure.
View raw filing on EDGAR →The filing discloses the death of William R. Berkley, the Company's founder and Executive Chairman, which is a material departure of a senior executive. While the section also mentions the appointment of W. Robert Berkley, Jr. as Chairman, the principal disclosed event centers on the founder's passing and the succession arrangement that follows, making this fundamentally an executive departure event.
View raw filing on EDGAR →Six directors (Catherine Szyman, Michelle Brennan, Quentin Koffey, Wendy Lane, Tim Scannell, and Darlene Solomon) resigned from the board, and three named executives (Catherine Szyman, Gregory Meehan, and Charles Dadswell) resigned from employment, all effective at the merger closing date.
View raw filing on EDGAR →Ketan Seth resigned as Chief Executive Officer and director of Blue Acquisition Corp effective immediately on June 9, 2026. While the filing also discloses David Bauer's appointment as interim CEO on the same day, the principal disclosed action centers on the CEO's departure. For a SPAC, CEO resignation is material to investors assessing management continuity and the company's ability to identify and consummate a business combination.
View raw filing on EDGAR →Dr. Anna Eramo, Chief Medical Officer, resigned effective June 15, 2026, and will transition to an advisor role. While the filing emphasizes that her departure is not expected to materially impact clinical development activities, the resignation of a CMO at a clinical-stage pharmaceutical company is a material executive departure that investors would consider significant. The separation agreement with severance and equity acceleration further confirms this is a formal executive departure event.
View raw filing on EDGAR →Craig Saldanha resigned as Chief Product Officer after four years in the role, representing a departure of a named executive officer in a C-suite position.
View raw filing on EDGAR →Michael A. Pollner, Senior Vice President, General Counsel & Secretary, provided notice of resignation effective June 30, 2026.
View raw filing on EDGAR →